IDH1 and central nervous system cancer: Although the presence of contrast enhancement on MR imaging is associated with tumor grade in IDH-mutant gliomas, this finding is neither sensitive or specific, and a substantial percentage of grade 2 oligodendrogliomas and IDH-mutant astrocytomas will demonstrate some level of enhancement.